YXY-25960-52715
1 vaccination
5 coded responses
16 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 420 / KY
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
- 2021-01-06
- 2021-01-07
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · HeadacheAdult check-in
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Office visit — Feeling: Fair · Headache · Get care from a doctor or other healthcare professionalFree text: OptometristMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Eye pain — Feeling: FairFree text: L eye painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — day 7, dose 1MedDRA: Eye pain — Feeling: FairFree text: L eye painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
- 2021-01-27
-
2021-02-03
Survey response — day 28, dose 1MedDRA: Unevaluable event, Uveitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Have uveitis in my left eye. Been seeing retinal specialist since one week post first vaccine. Seeing uveitis specialist next week. · Healthcare visit (other): Many eye doctor appointmentsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Report sent to call center — day 28, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-10
- 2021-02-17
-
2021-02-25
Call successfulParticipant prefers to complete VAERS report online
-
2021-04-07
Survey response — 3 months, dose 1MedDRA: Blindness, Eye pain, Latent tuberculosis, Ocular hyperaemia, Office visit, Pre-existing disease, Uveitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Vision loss from uveitis and latent tuberculosis in my left eye. Redness and mild tenderness in left eye. I believe vaccine caused my body to attack problems that were dormant · Healthcare visit (other): Appointment with a uveitis specialist at (b)(6). Also infectious disease specialist in (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-15
Call successfulCompleted over the phone
- 2021-07-07
- 2022-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | Successful | Participant prefers to complete VAERS report online |
| 2021-02-03 | Successful 2021-02-25 |
Participant prefers to complete VAERS report online |
| 2021-04-07 | Successful 2021-06-15 |
Completed over the phone |
Free text
Release 1 — days 1–6 daily, dose 1
Healthcare visit (other): Optometrist
Systemic reaction (other): L eye pain
Release 1 — day 7, dose 1
Systemic reaction (other): L eye pain
Release 3 — day 28, dose 1
Symptoms: Have uveitis in my left eye. Been seeing retinal specialist since one week post first vaccine. Seeing uveitis specialist next week.
Healthcare visit (other): Many eye doctor appointments
Release 7 — 3 months, dose 1
Symptoms: Vision loss from uveitis and latent tuberculosis in my left eye. Redness and mild tenderness in left eye. I believe vaccine caused my body to attack problems that were dormant
Healthcare visit (other): Appointment with a uveitis specialist at (b)(6). Also infectious disease specialist in (b)(6)
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ○ | ○ | ○ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Blindness | ✓ | ✓ | ✓ |
| SD | Eye pain | ✓ | ✓ | ✓ |
| SD | Latent tuberculosis | ✓ | ✓ | ✓ |
| SD | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Uveitis | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release